Indeed, mutations in several genes including CEBPA, FLT3, IDH1, MLL, and NPM1, and alternated expression of AF1q have been identified in the normal karyotype AML, and the potential value of these changes for clinical applications are under investigation [7], [8], [9]. The gene discussed is FLT3; the disease is acute myeloid leukemia.